MESHMD INC.
$160,000.00 CAD
≈ 2 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- October 1, 2019 – January 31, 2021
- Reference
- nrc-cnrc:172-2019-2020-Q3-935347
Published purpose
The hepMD platform will eliminate cumbersome paperwork and allow health care providers to quickly get their patients on to one of the new oral HCV therapies - Vosevi (Gilead Sciences Canada), Zepatier (Merck Canada), Maviret (Abbvie Canada). The portal will bring blockchain to prescription management as a novel way of dealing with the very problematic issue related to digitally prescribing pharmaceuticals in Canada.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions